Compile Data Set for Download or QSAR
Report error Found 67 Enz. Inhib. hit(s) with all data for entry = 50012715
TargetCathepsin S(Human)
Currently Naeja Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50121904([(S)-1-((3S,4R)-2-Oxo-4-phenoxy-azetidin-3-ylcarba...)
Affinity DataIC50: 0.100nMAssay Description:Inhibition of recombinant human cathepsin SMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProcathepsin L(Human)
Currently Naeja Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50121907([(S)-1-((3R,4S)-2-Oxo-4-phenylsulfanyl-azetidin-3-...)
Affinity DataIC50: 0.100nMAssay Description:Inhibition of recombinant human Cathepsin LMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProcathepsin L(Human)
Currently Naeja Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50121902([(S)-1-((2S,3R)-2-Benzenesulfonyl-4-oxo-azetidin-3...)
Affinity DataIC50: 0.100nMAssay Description:Inhibition of recombinant human Cathepsin LMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProcathepsin L(Human)
Currently Naeja Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50121904([(S)-1-((3S,4R)-2-Oxo-4-phenoxy-azetidin-3-ylcarba...)
Affinity DataIC50: 2.60nMAssay Description:Inhibition of recombinant human Cathepsin LMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin K(Human)
Currently Naeja Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50121902([(S)-1-((2S,3R)-2-Benzenesulfonyl-4-oxo-azetidin-3...)
Affinity DataIC50: 6.5nMAssay Description:Inhibition of recombinant human Cathepsin KMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin K(Human)
Currently Naeja Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50121907([(S)-1-((3R,4S)-2-Oxo-4-phenylsulfanyl-azetidin-3-...)
Affinity DataIC50: 8.40nMAssay Description:Inhibition of recombinant human Cathepsin KMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProcathepsin L(Human)
Currently Naeja Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50121903([(S)-1-((3R,4R)-2-Oxo-4-phenylsulfanyl-azetidin-3-...)
Affinity DataIC50: 15nMAssay Description:Inhibition of recombinant human Cathepsin LMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin K(Human)
Currently Naeja Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50121904([(S)-1-((3S,4R)-2-Oxo-4-phenoxy-azetidin-3-ylcarba...)
Affinity DataIC50: 16nMAssay Description:Inhibition of recombinant human Cathepsin KMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProcathepsin L(Human)
Currently Naeja Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50121912([(S)-1-((3S,4S)-2-Oxo-4-phenoxy-azetidin-3-ylcarba...)
Affinity DataIC50: 17nMAssay Description:Inhibition of recombinant human Cathepsin LMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin S(Human)
Currently Naeja Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50121911(Benzoic acid (2S,3S)-3-((S)-2-benzyloxycarbonylami...)
Affinity DataIC50: 20nMAssay Description:Inhibition of recombinant human cathepsin SMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin K(Human)
Currently Naeja Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50121908(3-Phenyl-propionic acid (2S,3S)-3-((S)-2-benzyloxy...)
Affinity DataIC50: 38nMAssay Description:Inhibition of recombinant human Cathepsin KMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin S(Human)
Currently Naeja Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50121908(3-Phenyl-propionic acid (2S,3S)-3-((S)-2-benzyloxy...)
Affinity DataIC50: 41nMAssay Description:Inhibition of recombinant human cathepsin SMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProcathepsin L(Human)
Currently Naeja Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50121901(Acetic acid (2S,3S)-3-((S)-2-benzyloxycarbonylamin...)
Affinity DataIC50: 42nMAssay Description:Inhibition of recombinant human Cathepsin LMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProcathepsin L(Human)
Currently Naeja Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50121908(3-Phenyl-propionic acid (2S,3S)-3-((S)-2-benzyloxy...)
Affinity DataIC50: 47nMAssay Description:Inhibition of recombinant human Cathepsin LMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin S(Human)
Currently Naeja Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50121902([(S)-1-((2S,3R)-2-Benzenesulfonyl-4-oxo-azetidin-3...)
Affinity DataIC50: 48nMAssay Description:Inhibition of recombinant human cathepsin SMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin K(Human)
Currently Naeja Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50121903([(S)-1-((3R,4R)-2-Oxo-4-phenylsulfanyl-azetidin-3-...)
Affinity DataIC50: 72nMAssay Description:Inhibition of recombinant human Cathepsin KMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProcathepsin L(Human)
Currently Naeja Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50121906([(S)-1-((2S,3S)-2-Isobutoxy-4-oxo-azetidin-3-ylcar...)
Affinity DataIC50: 91nMAssay Description:Inhibition of recombinant human Cathepsin LMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin K(Human)
Currently Naeja Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50121910([(S)-1-((2S,3S)-2-Butoxy-4-oxo-azetidin-3-ylcarbam...)
Affinity DataIC50: 100nMAssay Description:Inhibition of recombinant human Cathepsin KMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin K(Human)
Currently Naeja Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50121911(Benzoic acid (2S,3S)-3-((S)-2-benzyloxycarbonylami...)
Affinity DataIC50: 100nMAssay Description:Inhibition of recombinant human Cathepsin KMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin K(Human)
Currently Naeja Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50121901(Acetic acid (2S,3S)-3-((S)-2-benzyloxycarbonylamin...)
Affinity DataIC50: 100nMAssay Description:Inhibition of recombinant human Cathepsin KMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin K(Human)
Currently Naeja Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50121912([(S)-1-((3S,4S)-2-Oxo-4-phenoxy-azetidin-3-ylcarba...)
Affinity DataIC50: 100nMAssay Description:Inhibition of recombinant human Cathepsin KMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProcathepsin L(Human)
Currently Naeja Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50121910([(S)-1-((2S,3S)-2-Butoxy-4-oxo-azetidin-3-ylcarbam...)
Affinity DataIC50: 163nMAssay Description:Inhibition of recombinant human Cathepsin LMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProcathepsin L(Human)
Currently Naeja Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50121911(Benzoic acid (2S,3S)-3-((S)-2-benzyloxycarbonylami...)
Affinity DataIC50: 166nMAssay Description:Inhibition of recombinant human Cathepsin LMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin S(Human)
Currently Naeja Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50121901(Acetic acid (2S,3S)-3-((S)-2-benzyloxycarbonylamin...)
Affinity DataIC50: 207nMAssay Description:Inhibition of recombinant human cathepsin SMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin S(Human)
Currently Naeja Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50121912([(S)-1-((3S,4S)-2-Oxo-4-phenoxy-azetidin-3-ylcarba...)
Affinity DataIC50: 330nMAssay Description:Inhibition of recombinant human cathepsin SMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin S(Human)
Currently Naeja Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50121907([(S)-1-((3R,4S)-2-Oxo-4-phenylsulfanyl-azetidin-3-...)
Affinity DataIC50: 330nMAssay Description:Inhibition of recombinant human cathepsin SMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin S(Human)
Currently Naeja Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50121910([(S)-1-((2S,3S)-2-Butoxy-4-oxo-azetidin-3-ylcarbam...)
Affinity DataIC50: 355nMAssay Description:Inhibition of recombinant human cathepsin SMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin B(Rat)
Currently Naeja Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50121904([(S)-1-((3S,4R)-2-Oxo-4-phenoxy-azetidin-3-ylcarba...)
Affinity DataIC50: 430nMAssay Description:Inhibition of recombinant rat Cathepsin BMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin B(Rat)
Currently Naeja Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50121901(Acetic acid (2S,3S)-3-((S)-2-benzyloxycarbonylamin...)
Affinity DataIC50: 470nMAssay Description:Inhibition of recombinant rat Cathepsin BMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProcathepsin L(Human)
Currently Naeja Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50121909([(S)-1-((2S,3S)-2-tert-Butoxy-4-oxo-azetidin-3-ylc...)
Affinity DataIC50: 780nMAssay Description:Inhibition of recombinant human Cathepsin LMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin K(Human)
Currently Naeja Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50121906([(S)-1-((2S,3S)-2-Isobutoxy-4-oxo-azetidin-3-ylcar...)
Affinity DataIC50: 2.30E+3nMAssay Description:Inhibition of recombinant human Cathepsin KMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin K(Human)
Currently Naeja Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50121909([(S)-1-((2S,3S)-2-tert-Butoxy-4-oxo-azetidin-3-ylc...)
Affinity DataIC50: 2.50E+3nMAssay Description:Inhibition of recombinant human Cathepsin KMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin S(Human)
Currently Naeja Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50121906([(S)-1-((2S,3S)-2-Isobutoxy-4-oxo-azetidin-3-ylcar...)
Affinity DataIC50: 2.50E+3nMAssay Description:Inhibition of recombinant human cathepsin SMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin S(Human)
Currently Naeja Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50121905([(S)-1-((2S,3S)-2-Benzyloxy-4-oxo-azetidin-3-ylcar...)
Affinity DataIC50: 2.50E+3nMAssay Description:Inhibition of recombinant human cathepsin SMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin K(Human)
Currently Naeja Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50121905([(S)-1-((2S,3S)-2-Benzyloxy-4-oxo-azetidin-3-ylcar...)
Affinity DataIC50: 2.50E+3nMAssay Description:Inhibition of recombinant human Cathepsin KMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin S(Human)
Currently Naeja Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50121909([(S)-1-((2S,3S)-2-tert-Butoxy-4-oxo-azetidin-3-ylc...)
Affinity DataIC50: 2.50E+3nMAssay Description:Inhibition of recombinant human cathepsin SMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin S(Human)
Currently Naeja Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50121903([(S)-1-((3R,4R)-2-Oxo-4-phenylsulfanyl-azetidin-3-...)
Affinity DataIC50: 2.50E+3nMAssay Description:Inhibition of recombinant human cathepsin SMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin B(Rat)
Currently Naeja Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50121914([(S)-1-((S)-2-Oxo-azetidin-3-ylcarbamoyl)-2-phenyl...)
Affinity DataIC50: 2.70E+3nMAssay Description:Inhibition of recombinant rat Cathepsin BMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProcathepsin L(Human)
Currently Naeja Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50121905([(S)-1-((2S,3S)-2-Benzyloxy-4-oxo-azetidin-3-ylcar...)
Affinity DataIC50: 3.96E+3nMAssay Description:Inhibition of recombinant human Cathepsin LMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin S(Human)
Currently Naeja Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50121913([(S)-1-((R)-2-Oxo-azetidin-3-ylcarbamoyl)-2-phenyl...)
Affinity DataIC50: 5.00E+3nMAssay Description:Inhibition of recombinant human cathepsin SMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin K(Human)
Currently Naeja Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50121913([(S)-1-((R)-2-Oxo-azetidin-3-ylcarbamoyl)-2-phenyl...)
Affinity DataIC50: 5.00E+3nMAssay Description:Inhibition of recombinant human Cathepsin KMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin B(Rat)
Currently Naeja Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50121906([(S)-1-((2S,3S)-2-Isobutoxy-4-oxo-azetidin-3-ylcar...)
Affinity DataIC50: 6.46E+3nMAssay Description:Inhibition of recombinant rat Cathepsin BMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin B(Rat)
Currently Naeja Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50121910([(S)-1-((2S,3S)-2-Butoxy-4-oxo-azetidin-3-ylcarbam...)
Affinity DataIC50: 7.01E+3nMAssay Description:Inhibition of recombinant rat Cathepsin BMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin B(Rat)
Currently Naeja Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50121902([(S)-1-((2S,3R)-2-Benzenesulfonyl-4-oxo-azetidin-3...)
Affinity DataIC50: 7.39E+3nMAssay Description:Inhibition of recombinant rat Cathepsin BMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin B(Rat)
Currently Naeja Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50121908(3-Phenyl-propionic acid (2S,3S)-3-((S)-2-benzyloxy...)
Affinity DataIC50: 9.71E+3nMAssay Description:Inhibition of recombinant rat Cathepsin BMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetNeutrophil elastase(Human)
Currently Naeja Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50121901(Acetic acid (2S,3S)-3-((S)-2-benzyloxycarbonylamin...)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of human leukocyte elastase(HLE)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin B(Rat)
Currently Naeja Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50121907([(S)-1-((3R,4S)-2-Oxo-4-phenylsulfanyl-azetidin-3-...)
Affinity DataIC50: 1.05E+4nMAssay Description:Inhibition of recombinant rat Cathepsin BMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin B(Rat)
Currently Naeja Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50121912([(S)-1-((3S,4S)-2-Oxo-4-phenoxy-azetidin-3-ylcarba...)
Affinity DataIC50: 1.09E+4nMAssay Description:Inhibition of recombinant rat Cathepsin BMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin B(Rat)
Currently Naeja Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50121909([(S)-1-((2S,3S)-2-tert-Butoxy-4-oxo-azetidin-3-ylc...)
Affinity DataIC50: 1.14E+4nMAssay Description:Inhibition of recombinant rat Cathepsin BMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin B(Rat)
Currently Naeja Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50121913([(S)-1-((R)-2-Oxo-azetidin-3-ylcarbamoyl)-2-phenyl...)
Affinity DataIC50: 1.36E+4nMAssay Description:Inhibition of recombinant rat Cathepsin BMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
Displayed 1 to 50 (of 67 total ) | Next | Last >>
Jump to: